专题：Toxin Mechanisms and Immunotoxins

This cluster of papers focuses on the development and efficacy of immunotoxin therapy for cancer treatment, with a particular emphasis on ricin poisoning, ribosome-inactivating proteins, and targeted therapy using recombinant immunotoxins. It also explores the use of IL-13 receptor and mistletoe extract in cancer therapy.
最新文献
近5年高被引文献
Antibody drug conjugate: the “biological missile” for targeted cancer therapy

article Full Text OpenAlex 1628 FWCI162.7063

Antibody–drug conjugates come of age in oncology

review Full Text OpenAlex 851 FWCI47.2685

Exploring the next generation of antibody–drug conjugates

review Full Text OpenAlex 649 FWCI54.4348

Emerging new therapeutic antibody derivatives for cancer treatment

article Full Text OpenAlex 460 FWCI51.151

Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability

article Full Text OpenAlex 437 FWCI64.0709

Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals

article Full Text OpenAlex 290 FWCI151.9385

Antibody–drug conjugates: Recent advances in payloads

article Full Text OpenAlex 263 FWCI38.7648

Cancer therapy with antibodies

review Full Text OpenAlex 256 FWCI21.5051

Payload diversification: a key step in the development of antibody–drug conjugates

article Full Text OpenAlex 254 FWCI37.4456

The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development

article Full Text OpenAlex 250 FWCI56.9535